These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6882540)

  • 21. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of ACTH 1-17 on GH secretion in vitro.
    Ceda GP; Denti L; Valenti G
    Horm Metab Res; 1987 Aug; 19(8):361-3. PubMed ID: 2822561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of calcium channel antagonist (nicardipine) on growth hormone and prolactin secretion in pituitary adenomas].
    Kabuto M; Hayashi M; Kubota T; Kobayashi H; Nakagawa T; Katsumura H; Hosotani K
    No To Shinkei; 1991 Jul; 43(7):637-43. PubMed ID: 1910948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.
    Bassetti M; Spada A; Arosio M; Vallar L; Brina M; Giannattasio G
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical-pathological conference: prolactin-secreting adenohypophyseal adenoma.
    Johns Hopkins Med J; 1976 Apr; 138(4):146-57. PubMed ID: 1271603
    [No Abstract]   [Full Text] [Related]  

  • 26. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolactin-secreting pituitary adenomas in children and adolescents. Study of a series of 8 cases].
    Barrio R; Roger M; Chaussain JL; Job JC
    Arch Fr Pediatr; 1979; 36(8):785-93. PubMed ID: 539871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].
    Le Dafniet M; Blumberg-Tick J; Yuan Li J; Brandi AM; Bression D; Barret A; Feinstein MC; Peillon F
    C R Acad Sci III; 1988; 306(3):129-34. PubMed ID: 3126991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin secreting pituitary adenomas, treatment and results.
    Martinez Montes EA
    Prog Clin Biol Res; 1982; 112 Pt A():315-26. PubMed ID: 7163302
    [No Abstract]   [Full Text] [Related]  

  • 31. Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment.
    Polleri A; Masturzo P; Murialdo G; Agnoli A
    J Endocrinol Invest; 1981; 4(3):317-21. PubMed ID: 7320436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin gene expression in human growth hormone-secreting pituitary adenomas.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Sugita K; Matsui N
    J Neurosurg; 1990 Jun; 72(6):879-82. PubMed ID: 2338572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
    No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gonadotropin-releasing hormone associated peptide reduces calcium entry in prolactin-secreting cells.
    Vacher P; Mariot P; Dufy-Barbe L; Nikolics K; Seeburg PH; Kerdelhue B; Dufy B
    Endocrinology; 1991 Jan; 128(1):285-94. PubMed ID: 1986924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prolactin secreting pituitary neoplasms].
    Uozumi T; Mori S; Matsumura S
    Horumon To Rinsho; 1978 Oct; 26(10):1007-14. PubMed ID: 729180
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Light and electron microscopic observation of prolactin-secreting pituitary adenoma].
    Luo Y
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):595-7. PubMed ID: 6673928
    [No Abstract]   [Full Text] [Related]  

  • 40. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.